05:59 AM EDT, 08/07/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) reported Q2 adjusted earnings late Wednesday of $2.02 per diluted share, up from $0.43 a year earlier.

Analysts surveyed by FactSet expected $1.12.

Revenue for the quarter ended June 30 was $611.1 million, up from $362.9 million a year earlier.

Analysts polled by FactSet expected $530.7 million.

Shares of the company rose more than 11% in recent premarket activity Thursday.

Price: 18.15, Change: +1.89, Percent Change: +11.62